[Primary Generalized Glucocorticoid Resistance: a case report]

I I Larina1, N V Makazan1, K V Ivashchenko1

  • 1Endocrinology Research Centre.

Problemy Endokrinologii
|March 4, 2024
PubMed

Insights

Primary glucocorticoid resistance, a condition of insensitivity to glucocorticoids (GC), typically involves NR3C1 gene defects. This case highlights an adolescent with GC resistance despite no NR3C1 mutations, expanding the known genetic landscape of this rare disorder.

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Background:

  • Primary glucocorticoid resistance (PGR) is a rare disorder characterized by target organ insensitivity to glucocorticoids (GC).
  • It stems from defects in the human glucocorticoid receptor (hGR), leading to compensatory hypothalamic-pituitary-adrenal (HPA) axis activation.
  • Clinical manifestations vary, from asymptomatic cases to mineralocorticoid and/or androgen excess.

Observation:

  • This report details an adolescent patient presenting with clinical signs of glucocorticoid resistance.
  • Endocrinologic evaluations confirmed the patient's insensitivity to glucocorticoids.
  • Genetic analysis did not reveal mutations in the NR3C1 gene, the commonly associated gene for PGR.

Findings:

  • The patient exhibited features of glucocorticoid resistance.
  • No mutations were identified in the NR3C1 gene, challenging the established genetic basis for PGR.
  • This suggests potential novel genetic or epigenetic factors contributing to glucocorticoid resistance.

Implications:

  • The findings broaden the understanding of the genetic heterogeneity of primary glucocorticoid resistance.
  • This case underscores the need for comprehensive genetic screening beyond NR3C1 in suspected PGR cases.
  • Further research is warranted to identify alternative genetic or molecular mechanisms underlying this rare endocrinopathy.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
420